Viewing StudyNCT00471367



Ignite Creation Date: 2024-05-05 @ 5:31 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00471367
Status: TERMINATED
Last Update Posted: 2009-09-24
First Post: 2007-05-07

Brief Title: Phase I Open-label Dose-escalation Safety and PK Study of AZD4877
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Non-Hodgkin Lymphoma
Lymphoma
NHL
Keywords:
Name View
B-cell non-Hodgkin lymphoma View
Phase I View
AZD4877 View
Lymphoma View